Healthcare services group Uniphar said today that the business had performed in line with its expectations for 2023 at both a gross profit and EBITDA level.
In a trading update for the year to the end of December, Uniphar said it had achieved organic gross profit growth in excess of 5%.
It added that it continues to maintain a strong liquidity position, with lower than projected net debt by the end of the year.
Uniphar will publish its final results for 2023 on February 27, 2024.
Ger Rabbette, Uniphar's group chief executive, said today's trading update reflects a strong performance by the Group in 2023.
"Following early delivery on our IPO targets, we have created a new divisional structure to capitalise on our attractive growth opportunities and are now focused on reaching our ambitious new target of €200m EBITDA over the medium-term," the CEO added.
Uniphar shares were higher in Dublin trade today.
